Jægerspris Fodterapi ApS — Credit Rating and Financial Key Figures
CVR number: 39015676
Lejrvej 4, 3630 Jægerspris
klinik@jpfod.dk
tel: 22442212
www.jpfod.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 99.20 | 242.59 | 296.34 | 160.40 | 349.83 |
| Employee benefit expenses | -60.67 | - 302.74 | - 228.79 | - 170.41 | - 235.70 |
| Total depreciation | -8.85 | -8.85 | -11.67 | -33.04 | -17.04 |
| EBIT | 29.68 | -69.00 | 55.88 | -43.05 | 97.10 |
| Other financial income | 0.67 | ||||
| Other financial expenses | -1.83 | -23.49 | -43.84 | -18.42 | -3.15 |
| Pre-tax profit | 27.85 | -92.49 | 12.04 | -61.47 | 94.61 |
| Income taxes | -7.03 | 19.43 | -1.65 | 11.23 | -20.81 |
| Net earnings | 20.82 | -73.07 | 10.39 | -50.24 | 73.80 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 35.40 | 26.55 | 58.33 | 25.30 | 53.93 |
| Tangible assets total | 35.40 | 26.55 | 58.33 | 25.30 | 53.93 |
| Other receivables | 19.50 | 19.50 | 19.50 | 20.50 | 2.50 |
| Investments total | 19.50 | 19.50 | 19.50 | 20.50 | 2.50 |
| Long term receivables total | |||||
| Raw materials and consumables | 150.09 | 26.32 | 14.56 | ||
| Finished products/goods | 35.48 | 80.12 | |||
| Inventories total | 35.48 | 80.12 | 150.09 | 26.32 | 14.56 |
| Current trade debtors | 14.38 | 0.30 | 12.67 | 7.99 | 6.70 |
| Current amounts owed by group member comp. | 16.88 | 7.46 | |||
| Prepayments and accrued income | 16.71 | 16.55 | 9.62 | ||
| Current other receivables | 26.66 | 13.25 | |||
| Current deferred tax assets | 11.23 | 2.01 | |||
| Short term receivables total | 47.96 | 50.98 | 22.29 | 32.48 | 8.72 |
| Cash and bank deposits | 3.02 | 36.44 | 10.52 | 30.58 | 9.60 |
| Cash and cash equivalents | 3.02 | 36.44 | 10.52 | 30.58 | 9.60 |
| Balance sheet total (assets) | 141.37 | 213.58 | 260.73 | 135.17 | 89.31 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -15.41 | 5.41 | -67.65 | -57.27 | - 107.51 |
| Profit of the financial year | 20.82 | -73.07 | 10.39 | -50.24 | 73.80 |
| Shareholders equity total | 55.41 | -17.65 | -7.26 | -57.51 | 16.29 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 86.09 | 58.64 | 1.33 | ||
| Advances received | 25.15 | ||||
| Current trade creditors | 75.36 | 55.57 | 40.73 | ||
| Current owed to participating | 18.22 | 39.84 | 35.75 | ||
| Current owed to group member | 39.49 | ||||
| Short-term deferred tax liabilities | 1.65 | 11.59 | |||
| Other non-interest bearing current liabilities | 46.47 | 69.78 | 133.91 | 85.64 | 25.68 |
| Current liabilities total | 85.95 | 231.24 | 268.00 | 192.68 | 73.02 |
| Balance sheet total (liabilities) | 141.37 | 213.58 | 260.73 | 135.17 | 89.31 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.